Culture, Gender, and Health Care Stigma in Parkinsonism

帕金森病中的文化、性别和医疗保健耻辱

基本信息

项目摘要

DESCRIPTION (provided by applicant): The overall goal of the proposed research is to understand the stigmatizing role of the movement disorder of Parkinson's disease (PD) in health care practitioners' assessment of patient psychological traits, in the patient-practitioner relationship, and in the development of intervention recommendations. The first specific aim of the research is to elucidate the consequences of the operation of movement stereotypes on practitioner impressions of and conclusions about patients with PD. The second specific aim is to document the interaction of expressive masking (the diminishment of normal movement) with gender and culture on stigma outcomes. The third specific aim is to determine the degree to which practitioner expertise moderates the stigmatizing role of expressive masking on practitioner perceptions of and conclusions about patients. The fourth specific aim is to evaluate the clinical utility of the findings from the perspective of expert practitioners. Twelve Taiwanese patients (6 females and 6 males) and 12 American patients (6 females and 6 males) will be videotaped during a standardized health care interview in their respective homelands. Within each group of 6 patients (gender crossed with culture), there will be 3 patients with high expressive masking and 3 patients with normal expressive movement. Excerpts from the resulting 24 tapes will be shown to expert and novice health care practitioners in Taiwan and the U.S. who will assess patients' social and mental competence and potential for entering into a successful therapeutic relationship. In addition, the practitioners will make quality-of-life intervention recommendations. The results of the study will be presented to expert practitioners, in focus groups, who will evaluate the clinical utility of the findings and make recommendations for interventions to reduce practitioners' stigma responses. It is anticipated that PD with expressive masking will be more stigmatizing than PD without masking, especially as demonstrated in outcomes for novice compared to expert practitioners. It is also anticipated that negative outcomes of masking will be greater for female than male and American than Taiwanese patients because of different norms associated with movement expression in these groups.
描述(由申请人提供):拟议研究的总体目标是了解帕金森病(PD)运动障碍在医疗保健从业者评估患者心理特征、医患关系和制定干预建议中的污名化作用。本研究的第一个具体目的是阐明运动刻板印象对医生对PD患者的印象和结论的影响。第二个具体目标是记录表达性掩蔽(正常运动的减少)与性别和文化对耻辱后果的相互作用。第三个具体的目的是确定医生的专业知识在多大程度上缓和的污名化作用的表达掩蔽医生的看法和结论的病人。第四个具体目标是从专家从业者的角度评估研究结果的临床效用。12名台湾患者(6名女性和6名男性)和12名美国患者(6名女性和6名男性)将在各自的家乡进行标准化医疗保健访谈期间进行录像。在每组6名患者(性别与文化交叉)中,将有3名患者具有高表达掩蔽,3名患者具有正常表达运动。这24盘录音带的摘录将展示给台湾和美国的专家和新手医疗保健从业者,他们将评估患者的社会和心理能力以及建立成功治疗关系的潜力。此外,从业人员将提出生活质量干预建议。研究结果将提交给焦点小组的专业从业人员,他们将评估研究结果的临床效用,并提出干预措施的建议,以减少从业人员的污名反应。据预计,表达性掩蔽的PD将比没有掩蔽的PD更容易被污名化,特别是与专家从业者相比,新手的结局。也可以预期,掩蔽的负面结果将更大的女性比男性和美国比台湾患者,因为不同的规范与这些群体中的运动表达。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LINDA S TICKLE-DEGNEN其他文献

LINDA S TICKLE-DEGNEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LINDA S TICKLE-DEGNEN', 18)}}的其他基金

Emergence and evolution of social self-management of Parkinsons disease
帕金森病社会自我管理的出现和演变
  • 批准号:
    8640206
  • 财政年份:
    2013
  • 资助金额:
    $ 17.96万
  • 项目类别:
Emergence and evolution of social self-management of Parkinsons disease
帕金森病社会自我管理的出现和演变
  • 批准号:
    8820837
  • 财政年份:
    2013
  • 资助金额:
    $ 17.96万
  • 项目类别:
Emergence and evolution of social self-management of Parkinsons disease
帕金森病社会自我管理的出现和演变
  • 批准号:
    8438883
  • 财政年份:
    2013
  • 资助金额:
    $ 17.96万
  • 项目类别:
Emergence and evolution of social self-management of Parkinsons disease
帕金森病社会自我管理的出现和演变
  • 批准号:
    9262764
  • 财政年份:
    2013
  • 资助金额:
    $ 17.96万
  • 项目类别:
Culture, Gender, and Health Care Stigma in Parkinsonism
帕金森病中的文化、性别和医疗保健耻辱
  • 批准号:
    6940761
  • 财政年份:
    2003
  • 资助金额:
    $ 17.96万
  • 项目类别:
Culture, Gender, and Health Care Stigma in Parkinsonism
帕金森病中的文化、性别和医疗保健耻辱
  • 批准号:
    7387872
  • 财政年份:
    2003
  • 资助金额:
    $ 17.96万
  • 项目类别:
Culture, Gender, and Health Care Stigma in Parkinsonism
帕金森病中的文化、性别和医疗保健耻辱
  • 批准号:
    6684018
  • 财政年份:
    2003
  • 资助金额:
    $ 17.96万
  • 项目类别:

相似国自然基金

新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 批准年份:
    2010
  • 资助金额:
    26.0 万元
  • 项目类别:
    地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
  • 批准号:
    30960334
  • 批准年份:
    2009
  • 资助金额:
    22.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
  • 批准号:
    10657993
  • 财政年份:
    2023
  • 资助金额:
    $ 17.96万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10381163
  • 财政年份:
    2022
  • 资助金额:
    $ 17.96万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10531959
  • 财政年份:
    2022
  • 资助金额:
    $ 17.96万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10700991
  • 财政年份:
    2022
  • 资助金额:
    $ 17.96万
  • 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10518582
  • 财政年份:
    2022
  • 资助金额:
    $ 17.96万
  • 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10672973
  • 财政年份:
    2022
  • 资助金额:
    $ 17.96万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10585925
  • 财政年份:
    2022
  • 资助金额:
    $ 17.96万
  • 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
  • 批准号:
    10180000
  • 财政年份:
    2021
  • 资助金额:
    $ 17.96万
  • 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
  • 批准号:
    10049426
  • 财政年份:
    2021
  • 资助金额:
    $ 17.96万
  • 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
  • 批准号:
    10295809
  • 财政年份:
    2021
  • 资助金额:
    $ 17.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了